MedTrace Logo

Predictive Value of Bio-impedance Vector Analysis on Long-term Outcome in ICU Patients

NCT04449796 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1025

Last updated 2020-07-09

No results posted yet for this study

Summary

Phase angle, derived from bioimpedance analysis (BIA), reflects tissue quality and quantity in which cell mass, membrane integrity and hydration state are represented. Phase angle, as a measure of body composition, changes with the physical condition of patients and is associated with survival in several disease states and during ICU admission. Aim of the study is to explore the predictive value of the phase angle for long term ICU outcome.

Conditions

  • Long-term Outcome
  • Survival

Sponsors & Collaborators

  • Frisius Medisch Centrum

    lead OTHER

Principal Investigators

  • E.C. Boerma, MD PhD · Frisius Medisch Centrum

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-06-01
Primary Completion
2019-06-01
Completion
2020-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04449796 on ClinicalTrials.gov